Scandinavian Journal of Haematology · 1982 · 51 citations · 28 references
Life SciencesHematologyImmunologyCancer ImmunologyHematopathologyImmunopathologyCell-mediated ImmunityHelper T Cell SubsetsHuman Leukocyte Antigen SystemLeukocyte DisordersT Cell BiologyT Cell DifferentiationCd8 Positive T Cell ResponsesCd8 Positive T CellsImmunological AssaysProlymphocytic Leukemia
Cells from 13 cases of T-prolymphocytic leukaemia (T-PLL) were studied with a battery of immunological techniques in order to define their membrane phenotype. All cases were E-rosette positive and were negative with OKT6, anti-HLA-DR, anti-Ig and M-rosettes; in 3, 20-30% of the cells had receptors for C3b. 7 cases had predominantly a 'helper/inducer' T-subset phenotype, (OKT4+, OKT8-) and 4 had a 'suppressor/cytotoxic' phenotype (OKT8+, OKT4-). Cells in 2 cases coexpressed OKT4 and OKT8 in 48% and 95% of prolymphocytes and in another, both OKT4 and OKT8 were negative. Terminal transferase (TdT) was negative by IF in all the cases, but a low positive level was detected biochemically in one. Although T-PLL appears to be heterogenous in respect of membrane phenotype, the observation of unexpected features in 8 of the cases raises the possibility that it may originate in a cell of intermediate maturation between late thymocytes and mature T-lymphocytes. These features plus the clinical manifestation of the disease - typical morphology, splenomegaly, lymphadenopathy, skin lesions, high WBC and aggressive clinical course - help define T-PLL as a distinct clinicopathological entity.
28
Ellis L. Reinherz, Patrick C. Kung, Gideon Goldstein et al. · Proceedings of the National Academy of Sciences · 1980 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +17
Terminal deoxynucleotidyl transferase as a hematopoietic cell marker
The Sézary syndrome: a malignant proliferation of helper T cells.
S Broder, Richard L. Edelson, Marvin A. Lutzner et al. · Journal of Clinical Investigation · 1976 · 481 citations · Full text